Latest / Stock Movers / KDP Sees Boost From JDE Peet’s; Planet Fitness Shares Fall; Hims’ Falls on Fears Over Copycat Drugs
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, podcasts, radio news, The Stock Movers Report,
- 0:10Speaker 1: your roundup of companies making moves in the stock market,
- 0:13Speaker 1: harnessing the power of Bloomberg Data.
- 0:16Speaker 2: Let's take a look at some stocks on the move
- 0:18Speaker 2: today with the Lexustoffers.
- 0:20Speaker 3: All right, guys, I want to start with Curig Doctor
- 0:22Speaker 3: Pepper having a good morning, up two and a half
- 0:24Speaker 3: percent of about six percent a year to date. You know,
- 0:28Speaker 3: I was looking at some of their brands. Some I
- 0:30Speaker 3: knew they had, some I didn't, of course, Doctor Pepper,
- 0:33Speaker 3: the brewing systems, Snapple Canada, Dry didn't realize they owned
- 0:37Speaker 3: buy Crush, Mott's Apple Sauce.
- 0:40Speaker 4: Really okay, yeah, pretty big portfolio like Doctor Pepper. But
- 0:43Speaker 4: I just don't drink it often. I don't see it
- 0:45Speaker 4: that all.
- 0:45Speaker 3: You don't see it, right, Yeah, I don't know. It's
- 0:47Speaker 3: got like a weird aftertaste for me.
- 0:48Speaker 4: But it's definitely unique in each two his own. All right.
- 0:51Speaker 3: They're offering an upbeat forecast for full year sales, and
- 0:53Speaker 3: they expect a boost from their planned buyout of the
- 0:56Speaker 3: Dutch coffee maker Piezz. You know, you see pizza. You
- 0:59Speaker 3: don't have a lot here in the city but it's
- 1:01Speaker 3: happening because there was a lot of skepticism over the
- 1:04Speaker 3: amount of debt that Kurg was taking on acquiring Pete.
- 1:07Speaker 3: So the company earlier this week said it was going
- 1:09Speaker 3: to raise an additional one and a half billion in
- 1:11Speaker 3: capital in an effort to reduce its leverage.
- 1:13Speaker 2: Janking for doing this, I just said, folks, I used
- 1:16Speaker 2: Google Gemini here, that's what we use within to try
- 1:18Speaker 2: to make our conversation smarter. They're outpacing PEPSI. Yeah, I
- 1:23Speaker 2: would have never known that.
- 1:24Speaker 3: I'm telling it. It's pretty crazy. Well maybe because some of
- 1:27Speaker 3: the drinks.
- 1:27Speaker 2: I mean, can we get a can we get a
- 1:29Speaker 2: Tito's and doctor Pepper? So can we work on that?
- 1:33Speaker 3: That'd be interesting next. All right, Planet Fitness, I don't
- 1:36Speaker 3: get this, Okay that the stock is down five percent.
- 1:39Speaker 3: It had higher profit and revenue in the fourth quarter,
- 1:42Speaker 3: added members, opened new locations, and it's even forecasting growth ahead.
- 1:47Speaker 3: I think the problem here is the growth is not
- 1:49Speaker 3: as robust as Wall Street expected. So it's another one
- 1:52Speaker 3: of those expectations. Yeah, the bar is now so high.
- 1:56Speaker 3: It expects adjusted earnings to grow nine to ten percent,
- 1:59Speaker 3: revenue to increase about nine percent, and it's going to
- 2:03Speaker 3: see revenue climb. Yeah, revenue climbed eleven percent last quarter.
- 2:08Speaker 3: Also opened up a bunch of new gyms and added
- 2:11Speaker 3: one point one million new subscribers. So you hamped the
- 2:14Speaker 3: new Hampshire.
- 2:15Speaker 2: Sure, I would have never known. No, I'm looking here
- 2:18Speaker 2: at the ten year track record and it's better than
- 2:21Speaker 2: my workout regime. Are you kidding me? Planet Fitness ten
- 2:24Speaker 2: year track record twenty two percent per year? Really?
- 2:28Speaker 4: Oh that's cotton chiseled. Yeah, absolutely, there you load love, yeah,
- 2:32Speaker 4: of course, yeah, out there in the West coast.
- 2:34Speaker 2: Thanks.
- 2:34Speaker 3: All right, let's go to Hymn's and Hers Health. It
- 2:37Speaker 3: has been a rough start to the year for this company.
- 2:40Speaker 3: It's a telehealth company. Down six percent UH today alone
- 2:44Speaker 3: and down fifty two percent so far this year. Weaker
- 2:47Speaker 3: outlook for the first quarter, and the company is also
- 2:50Speaker 3: refusing to answer questions about its ability to sell these
- 2:54Speaker 3: compounded versions. Understand where these knockoffs of the weight loss
- 2:58Speaker 3: drugs from like that are similar to Novo Nordisks and
- 3:01Speaker 3: Eli Lilly's drugs. So it said sales for the year
- 3:04Speaker 3: are going to be between two point seven and two
- 3:06Speaker 3: point nine billion, just matching estimates. But What really happened
- 3:10Speaker 3: here is competition in the obesity market is very strongly
- 3:14Speaker 3: right right now, and it botched the launch of a
- 3:17Speaker 3: copycat version of Novo Nordist's new weight loss pill, and
- 3:21Speaker 3: now Novo is suing Hymns and Her.
- 3:23Speaker 4: I understood the premise for this company in the first place,
- 3:26Speaker 4: right thought. The whole patent stuff is there for a reason.
- 3:29Speaker 2: I mean, I can.
- 3:30Speaker 3: Understand if they were jumping into the fray once these
- 3:32Speaker 3: drugs came off patent, but it seems like they're not.
- 3:34Speaker 4: And it's the whole concept of they're making these compounds,
- 3:37Speaker 4: which I don't fully understand.
- 3:39Speaker 3: Because they're hoping they're different enough, just enough that it'll
- 3:42Speaker 3: pass muster. But now the SEC is also bringing action
- 3:44Speaker 3: against them, So Hymns and Her are some real challenges
- 3:46Speaker 3: there for the company.
- 3:48Speaker 1: This stock mover's report from Bloomberg Radio. Check back with
- 3:52Speaker 1: us throughout the day for the latest roundup of companies
- 3:55Speaker 1: making news on Wall Street and for the latest market
- 3:58Speaker 1: moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube,
- 4:02Speaker 1: Bloomberg dot com, and on Applecarplay and Android Auto with
- 4:06Speaker 1: the Bloomberg Business app.